Dr. Joloba recognised for his efforts to end Tuberculosis

Dr.Moses Joloba. (COURTESY PHOTO).

The U.S. Centers for Disease Control and Prevention’s Division of Global HIV and TB ( CDC Global) has recognised Uganda’s Director for the National Tuberculosis (TB) Reference Laboratory, Dr. Moses Joloba for his efforts to end the disease, as part of the 2022 Global TB Elimination Champions.

Dr. Moses Joloba,has built capacity for TB diagnosis and surveillance for over 25 years. His leadership was instrumental in expanding the use of the GeneXpert platform, which helps quickly diagnose drug-resistant TB.


Using the Strengthening Laboratory Management Toward Accreditation (SLMTA) approach to train laboratory managers to implement quality management systems, CDC Uganda has supported National TB Reference Laboratory (NTRL) to attain international accreditation for both ISO 15189 and ISO 17043 standards through the South Africa National Accreditation System (SANAS) – contributing to increased timeliness, reliability, and accuracy of testing.

This also means that NTRL now experiences fewer adverse safety incidents and the public and policy makers have higher confidence in its laboratory services due to increased quality, lower wait times for patients, and enhanced interactions with clinicians.

Dr. Moses Joloba is arguably the most published researcher in the Tuberculosis world in Uganda. Under his leadership the National Tuberculosis Reference Laboratory, was awarded the status of supranational Tuberculosis reference laboratory, the second of the nature on the whole continent.

He was not only instrumental in establishing laboratories of molecular biology, immunology and Mycobacteriology at Makerere University but also his tenacious work on better TB diagnostic tools and drugs (pharmacokinetics) has won him international acclaim as Tb laboratory consultant for World Health Organisation.